Abstract IA015: Immunoprevention of triple negative breast cancer by TOP2A derived peptide vaccination
Sang Beom Lee(Medical College of Wisconsin), Ming You(Houston Methodist), Jeffrey E. Green(Northwestern University), Shizuko Sei(National Cancer Institute), Donghai Xiong(Medical College of Wisconsin), Bryon D. Johnson(Medical College of Wisconsin), Katie Palen(Medical College of Wisconsin), Robert H. Shoemaker(Frederick National Laboratory for Cancer Research), Pan Jing(Houston Methodist), Yian Wang(Hunan Normal University), Ronald A. Lubet(National Cancer Institute)
Cited by 0
Related Papers
TSC2 Integrates Wnt and Energy Signals via a Coordinated Phosphorylation by AMPK and GSK3 to Regulate Cell Growth
|Cell|2006|1.4k
Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors
|Genome biology|2007|1.3k
Neoantigen vaccine: an emerging tumor immunotherapy
|Molecular Cancer|2019|718
Autophagy promotes the survival of dormant breast cancer cells and metastatic tumour recurrence
|Nature Communications|2018|418
A gene expression signature of TREM2hi macrophages and γδ T cells predicts immunotherapy response
|Nature Communications|2020|246